You're going to hear a lot more about "ASA resistance"

You're going to hear a lot more about "ASA resistance." Now that millions of people take low-dose ASA to prevent cardiovascular disease, we're seeing that it doesn't always work.

About 10% of the population might be resistant to ASA's antiplatelet effects. These patients might be up to 3 times more likely to die of cardiovascular disease.

Two tests for ASA resistance are already on the market... AspirinCheck and AspirinWorks.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote